CareDx(CDNA)2025-02-26 21:09Financial Results and Guidance - CareDx, Inc. announced preliminary financial results for Q4 and the year ended December 31, 2024[4]. - The company provided 2025 revenue guidance, details of which are included in the press release[4]. - The financial results and guidance are intended to inform stakeholders and are not deemed "filed" under the Exchange Act[5]. - The company has not disclosed specific financial figures in the provided documents[4]. Corporate Communication - The corporate presentation dated January 13, 2025, is intended to be posted on the company's website[6]. - The press release and corporate presentation are attached as Exhibits 99.1 and 99.2, respectively[9]. - The report was issued on January 13, 2025, indicating the company's commitment to timely communication with investors[12]. Company Information - CareDx, Inc. is registered under the Securities Exchange Act of 1934 and is listed on The Nasdaq Stock Market LLC with the symbol CDNA[2]. - The company is not classified as an emerging growth company under the relevant regulations[3]. - The report was signed by John W. Hanna, President and CEO of CareDx, Inc.[13].